chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Temperature 101.3; This spontaneous case was reported by a physician and describes the occurrence of PYREXIA (Temperature 101.3) in a 32-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 038A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 21-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 22-Mar-2021, the patient experienced PYREXIA (Temperature 101.3). At the time of the report, PYREXIA (Temperature 101.3) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 22-Mar-2021, Body temperature: 101.3 (High) 101.3 increased.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No relevant concomitant medications were reported. The patient did not take any treatment medication.
20 y/o Mexican female c/o headache 5/10 15 mins after receiving the 2nd dose of the vaccine. She denies having any PMH. She was assessed and monitored by NP, EMT, and paramedic. BP - 114/74, HR - 81, resp - 14, O2 sat - 98% on RA. She was given H2O, she briefly removed her mask and she reported that she felt better after interventions. She was kept at site until she had no complaints and noted that she felt better. She was given the Vaccination information sheet, reinforced instructions on ADRs/SEs to call 911 and go to the ED, follow up with her PCP, register with V-safe. She verbalized understanding and willingness to comply. She left site with family members in no acute distress, awake, alert, oriented, to person, place, time and situation.
No adverse effects were reported; A patient received an improperly stored ROTATEQ; This spontaneous report was received from a medical assistant regarding a patient of unknown age and gender. There was no information reported about the patient's concomitant medications, pertinent medical history and drug reactions or allergies.   On approximately 04-NOV-2019 (reported as: 04-NOV-2019 or 05-NOV-2019), the patient received an improperly stored dose of Rotavirus Vaccine, Live, Oral, Pentavalent (ROTATEQ) for prophylaxis (lot number S004253 and expiration date 21-OCT-2020 have been verified to be a valid; dose, route of administration and anatomical site were not provided). The lowest temperature the vaccine was exposed to was below 36 Fahrenheit degrees / 2 Celsius degrees (1.3 Celsius) within a time frame of 2 hours and 18 minutes. There was no previous temperature excursion and the call was because of a data logger. No adverse effects were reported.   This is one of several reports from the same reporter (information captured #:1911USA002388, 1911USA001917, 1911USA004087, 1911USA002263, 1911USA001946, 1911USA002198, 1911USA002043, 1911USA002053 and 1911USA002033); Sender's Comments:  US-009507513-1911USA002388: US-009507513-1911USA001917: US-009507513-1911USA004087: US-009507513-1911USA002263: US-009507513-1911USA001946: US-009507513-1911USA002198: US-009507513-1911USA002043: US-009507513-1911USA002053: US-009507513-1911USA002033:
Started throwing up milk and would not keep anything down. Was taken by to doctor office the next day and was told to give something for it and then try to give the baby milk again.
HI, couple days after my son (17 years old) got the 2nd shot he was heaving a pressure in his chest and left arm so we rushed him to the hospital. When we got to the hospital with his level of  26 (normal 1) and blood test show also lever inflammation they hospitalized him right away.   He was there 3 days and just got released.  now he need to be  under care with medication and visit to  a heart cardiology doctor every few days for tests.  he cannot do any activity (per to the doctor including computer games that can raise his heart rate)
had to crawl on the floor; felt very tired; tried to stand then severe dizziness and crumbled to the floor; had severe dizziness; severe vertigo that night after the vaccine,room was spinning; This spontaneous case was reported by a physician and describes the occurrence of VERTIGO (severe vertigo that night after the vaccine,room was spinning), GAIT DISTURBANCE (tried to stand then severe dizziness and crumbled to the floor), DIZZINESS (had severe dizziness), FORMICATION (had to crawl on the floor) and FATIGUE (felt very tired) in an 80-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No medical history   .  The patient's past medical history included No adverse event (Past medical history was not provided). Concomitant products included ATORVASTATIN, METOPROLOL, LISINOPRIL, AMLODIPINE, LEVOTHYROXINE and FINASTERIDE for an unknown indication.    On 05-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 05-Mar-2021, the patient experienced VERTIGO (severe vertigo that night after the vaccine,room was spinning). On 06-Mar-2021, the patient experienced GAIT DISTURBANCE (tried to stand then severe dizziness and crumbled to the floor), DIZZINESS (had severe dizziness) and FATIGUE (felt very tired). On an unknown date, the patient experienced FORMICATION (had to crawl on the floor). At the time of the report, VERTIGO (severe vertigo that night after the vaccine,room was spinning), GAIT DISTURBANCE (tried to stand then severe dizziness and crumbled to the floor), DIZZINESS (had severe dizziness), FORMICATION (had to crawl on the floor) and FATIGUE (felt very tired) was resolving.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Treatment information was not provided.
This spontaneous case reported by a consumer, describes the occurrence of pyrexia (fever), chills, peripheral swelling (swollen arm) and pruritus (itchy arm) in a 56-year-old female patient who received mRNA-1273 (Moderna COVID-19 vaccine, batch# 003B21A and 024M20A) for COVID-19 vaccination. No medical history reported. On Mar 3, 2021, patient received the first dose of mRNA-1273 (Moderna COVID-19 vaccine), intramuscular; 1 dosage form. On Mar 31, 2021, received the second dose of mRNA-1273 (Moderna COVID-19 vaccine), unknown route; 1 dosage form. On Mar 31, 2021, patient experienced pyrexia (fever), chills, peripheral swelling (swollen arm) and pruritus (itchy arm). At the time of the report, pyrexia (fever), chills, peripheral swelling (swollen arm) and pruritus (itchy arm) outcome: unknown/not provided.
Pt experienced syncopal episode after her 1st HPV vaccine. Pt hit her nose on a counter. Pt was helped to a wheelchair. Given ice packs, juice and crackers. BP taken. 110/60. Pt recovered and was able to walk out of office with mom.
PATIENT WAS 11 YEARS OLD AT THE TIME OF VACCINATION AND NOT ELIGIBLE FOR THE VACCINE.  NO PHYSICAL SYMPTOMS REPORTED.
The site of my injection seems to be getting worse 10 days after the injection. It?s not very painful, but is a little warm.
wheezing; coughing; This is a solicited report received from contactable reporter(s) (Consumer or other non HCP).  A 66-year-old female patient received rsv vaccine prot.subunit pref 2v (RSV VACCINE PROT.SUBUNIT PREF 2V), on 26Sep2023 as dose number unknown, single (Batch/Lot number: unknown) at the age of 66 years for immunisation; for immunisation; treprostinil sodium (REMODULIN), first regimen (Batch/Lot number: unknown) at 0.05 ug/kg (0.050 ug/kg) and second regimen since Apr2021 (ongoing) (Batch/Lot number: unknown), all intravenous for pulmonary arterial hypertension; influenza vaccine (INFLUENZA VACCINE), on 26Sep2023 as dose number unknown, single (Batch/Lot number: unknown) for immunisation. The patient's relevant medical history included: "Pulmonary arterial hypertension" (ongoing). Concomitant medication(s) included: TADALAFIL. The following information was reported: COUGH (medically significant) with onset Sep2023, outcome "unknown", described as "coughing"; WHEEZING (medically significant) with onset Sep2023, outcome "unknown". The events "wheezing" and "coughing" required emergency room visit. She stated that her symptoms were not severe enough to go to the ER (emergency room) and wanted to knew if there is anything she could take. She was advised that there was nothing over the counter, but her MD (physician) could possibly prescribe something. The action taken for treprostinil sodium was dosage not changed.  The reporter did not provide causality for the events of cough and wheezing with IV Remodulin. The reporter's causality for the events of cough and wheezing with flu vaccine and RSV vaccine was considered to be possibly related.  The information on the batch/lot number for rsv vaccine prot.subunit pref 2v, rsv vaccine prot.subunit pref 2v  has been requested and will be submitted if and when received.; Sender's Comments: There is not a reasonable possibility that the reported events wheezing and cough were related to the suspect product, however based on the temporal association possible causal association cannot be exclucde
Information has been received from a physician concerning a female patient who on an unknown date was vaccinated with a second dose of Gardasil. Subsequently, the patient developed widespread itching. The patient contacted the office but no treatment was required. It was reported that the remainder of the vaccine series was discontinued. At the time of this report, the patient's outcome was unknown. No product quality complaint was involved. Additional information has been requested.
Patient developed erythema 7.5 cm x 4 cm around injection site. Skin warm to touch. BENADRYL and Ibuprofen were administered with decrease in symptoms.
Patient has a big, red bullseye spot at the site of injection that is hot to the touch and inflammed. There is a nodule below the site of injection. Patient has reported some itching as well.
Patient was given a third dose of covid-19 vaccine in error.  His records at our health center did not indicate he was given a second covid-19 vaccine at an outside facility on 1/21/22. The State registry did not show the second vaccine given on 1/21/22 in the system. The guardian with the patient was not aware that patient had received his second dose of covid-19 vaccine while under the care of the other parent who was not present at appointment. He reported fever to 103 and left arm pain on 2/9/22, but is being managed at home with OTC pain relievers and fever reducers.
FOCAL MOTOR SEIZURE ACUTE STROKE DUE TO ISCHEMIA, UNSPECIFIED TYPE AND ARTERY LEFT FACIAL MUSCLE WEAKNESS
This spontaneous report as received from a physician assistant via a field representative refers to an 11 year old patient of unknown gender. Concomitant medication and pertinent medical history is not provided. On an unknown date the patient was vaccinated with an extra dose (fourth dose) of GARDASIL. It is unspecified if the patient had any adverse effects from the extra dose of GARDASIL. Additional information has been requested.
administration of expired Moderna vaccine; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (administration of expired Moderna vaccine) in a 69-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 006C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 18-Nov-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 18-Nov-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (administration of expired Moderna vaccine). On 18-Nov-2021, EXPIRED PRODUCT ADMINISTERED (administration of expired Moderna vaccine) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant medication of the patient was not reported.   No treatment was given to the patient.   The vaccines were stored in freezer, were taken out one to two vials and placed in fridge each day as needed.
Pt presented 11 days after vaccination given. Pt complained of injection site pain and showed extreme bruising. Bruising appeared to be resolving. Also, pt complained of "lump"... not visible.
redness, warmth, itching  at injection site that started 3/20/2021, treated with po Zyrtec daily
Left upper arm is slightly swollen and red around injection site. Denies fever or pain. Child moving arm well.
resident coded and expired; This is a spontaneous report from a non-contactable consumer via Pfizer Sponsored Program.  A 63-year-old male patient received the 1st dose of bnt162b2 (BNT162B2, Lot # EH9899) intramuscular at single dose at left arm on 28Dec2020 for Covid-19 immunisation.  Medical history included no current Illness, no known allergies, but preexisting conditions: dysphagia, violent behaviors, depressive disorder, schizophrenia, aspiration, gastrooesophageal reflux disease (GERD), hyperlipidaemia, bipolar disorder, rectal bleeding, hypertension. The patient had no birth defect. Concomitant medication included asa (ASA) at 81mg, lisinopril (LISINOPRIL) at 10mg daily, ferrous sulfate (FERROUS SULFATE) at 325 (unit unknown), olanzapine (ZYPREXA) at 20mg, morniflumate (FLOMAX [MORNIFLUMATE]) at 0.4 (unit unknown), famotidine (FAMOTIDINE) at 20mg, ascorbic acid (VIT C), carbamazepine (CARBAMAZEPINE) at 250mg bid, valproate semisodium (DEPAKOTE) at 750mg bid, metformin (METFORMIN) at 1000 (unit unknown) bid, sertraline (SERTRALINE) at 100 (unit unknown) bid, albuterol [salbutamol] (ALBUTEROL [SALBUTAMOL]), buspirone hydrochloride (BUSPAR) at 10mg tid, polycarbophil calcium (FIBERCON).  The patient died on 29Dec2020. The patient had no ER or Doctor visit and was not hospitalized. It was not reported if an autopsy was performed.  No follow-up attempts are possible. No further information is expected.; Reported Cause(s) of Death: resident coded and expired
Flu-like feeling; Achy; Injection site was hurting for about three days; This spontaneous case was reported by a patient and describes the occurrence of INFLUENZA LIKE ILLNESS (Flu-like feeling), MYALGIA (Achy) and VACCINATION SITE PAIN (Injection site was hurting for about three days) in a 68-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 007M20A) for COVID-19 vaccination.     No Medical History information was reported.   On 12-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 12-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 12-Feb-2021, the patient experienced INFLUENZA LIKE ILLNESS (Flu-like feeling), MYALGIA (Achy) and VACCINATION SITE PAIN (Injection site was hurting for about three days). At the time of the report, INFLUENZA LIKE ILLNESS (Flu-like feeling), MYALGIA (Achy) and VACCINATION SITE PAIN (Injection site was hurting for about three days) outcome was unknown. Not Provided      mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) and mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) dosing remained unchanged.       Concomitant medications were not reported. Treatment details not provided.  Patient will receive  2nd dose on 12-Mar-2021., her concern is that can she take Ibuprofen and excedrin before or after vaccination.   This case was linked to MOD-2021-204761 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 11-Mar-2021: Follow up information received on 11mar2021 contains significant information ,updated start date of events, reporter information and patient information (DOB). On 07-Jun-2021: Follow-up information received on 07-Jun-2021 and contains non-significant information
This spontaneous report as received from a physician via a company representative refers to a female patient of unknown age with unspecified pertinent medical history, drug reactions or allergies. On an unknown date, the patient was vaccinated with a dose of GARDASIL (dose, lot number and route were not provided). Concomitant medication was not reported. On an unknown date, while on therapy with GARDASIL, the patient experienced fatigue and abdominal pain. The patient sought medical attention by visiting the physician. The outcome of abdominal pain and fatigue was unknown. Additional information has been requested.
severe back pain (ongoing 1 week), vertigo, extreme dizziness, pins and needles in hands and arms, fatigue
C/O soreness @ 13:30 from pneumonia injection site. arm is swollen - c/o tenderness into arm and to axilla. Unable to raise Right arm above head level.
didn't feel great; three days he got nauseous; This is a spontaneous report from a contactable consumer or other non-healthcare professional. A 41-year-old male patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection), via an unspecified route of administration on an unspecified date (Batch/Lot number was not reported) as single dose for COVID-19 immunisation. The patient medical history and concomitant medications were not reported. The patient received the Pfizer shot, he had a few underlying conditions, when he got his first shot, he didn't feel great. For three days he got nauseous, he did not know if it was a coincidence. Later he got his second shot. Outcome of events was unknown.   Information on the lot/batch number has been requested.
patient complained of runny nose, headache, fatigue, cough from post nasal drip at around 4:00pm , vaccine was given that morning at 10:45am.
I had a complete hysterectomy in March of 2021 with no complications .  Over 2 months later, 13 days after the vaccine I started vaginal bleeding which is inexplicable because I no longer have a uterus.
Information has been received via the Merck pregnancy registry, from a physician, concerning a 17 year old female patient who was 2-3 weeks pregnant in October 2007, when she was vaccinated with the first dose of Gardasil (lot # not reported). On 13-JAN-2008, the patient had a miscarriage and was hospitalized (details and dates not provided). The physician stated that the patient was "traumatized." At the time of this report, the outcome of miscarriage and patient traumatized was unknown. The physician considered the miscarriage to be disabling/incapacitating due to the patient being traumatized. Additional information has been requested.
Patient received first dose of Moderna vaccine on 5/26/2021 and second dose on 7/14/21. Patient received 3rd dose of Moderna booster by error on 11/19/2021 despite lack of 6 months between time of receiving second dose.
Left arm was a little sore and felt hot.  The next morning her arm was swollen, had chills, upset stomach, redness.  patient did NOT have a rash, fever, or trouble breathing.
Fever 101; swelling at injection site 6in by 4in, tender, erythema for 4 days
night of shot could barely walk..pain & aches were abnormally severe.  24 hrs later i was able to get up & sit on couch & have soup...then began sinus severe pain & pressure which lasted 2 more days along with more aching.  Then Thursday i developed an infection in my mouth..mainly on my gums.  Drs office gave me script for zpak & prednisone directing me to hold off unless needed badly in order not to jeopardize the vaccine.  Dr. (PA) felt it was a bad reaction to the vaccine.
Fever x 5 hours, arthalgias, HA, chills. Right arm with 7cm area of induration, redness, pain, some itching with axillary lymphadenopathy.
After the vaccination was administered, it was discovered that the patient had received a full, two dose course of the Pfizer Covid 19 vaccine on 2/27/21 & 3/20/21.
Rash at site of vaccine on day 5 Extreme fatigue and weakness on day 6 and 7
Depression, difficulty sleeping/concentrating, short term memory loss. Itchy rash on bil legs since Dec 03 after 4th shot. Constant ringing in bil ears. Recurrence of left shoulder pain. Knots in arms with swelling on all four shots-last a little over 1 wk for all shots. lower abd pain 1 month after 1st shot, burst cyst on right ovary,bil removal of tubes/ovaries at various times. Diagnosed with endometriosis with no prior hx. Partial Hysterectomy 1998. Still having abd pain causing problems doing her assigned duties. Mood swings, nasal drainage and bil knee pain without exercise.
4/6/16 - seen in the office with 2" red indurated area Lt deltoid around vaccine site. Dx local rxn. Tx: BENADRYL, compresses. 4/7/16 phone call - lower arm red and swollen too same tx. 4/18/16 - brought pictures - 2 hives around injection site. Lost weight, a bit red. Was much better prior to that. Recommended ZYRTEC, see allergist.
Tightness in throat for 15 minutes; light fever; feeling very sluggish; pain when the vaccine was administered.; This is a spontaneous report from a contactable consumer (patient). A 21-years-old male patient received first dose of bnt162b2 (BNT162B2, Formulation: Solution for injection, Lot number and Expiration date: unknown), via an unknown route of administration, in left arm on 30Apr2021 at 16:30 (at the age of 21-years-old) as First dose , single dose for covid-19 immunisation. Medical history included crohn's disease, coeliac disease, asthma and Bactrim allergy. Concomitant medications included amoxicillin (AMOXIL), codeine phosphate, paracetamol (TYLENOL WITH CODEINE) and ibuprofen (IBUPROFEN) taken for an unspecified indication. Patient has not received any other vaccine in four weeks. Prior vaccination, patient was not diagnosed with covid-19. Since the vaccination, patient has not tested positive for covid-19. On 30Apr2021 at 16:30, the patient experienced tightness in throat for 15 minutes, light fever, feeling very sluggish and pain when the vaccine was administered. Therapeutic measures were taken as a result of tightness in throat for 15 minutes, light fever, feeling very sluggish and pain. Treatment received for the events included Tylenol 500 mg. Outcome of events was recovering.  No follow-up attempts needed. No further information is expected.
patient felt lightheaded approx 15 minutes after injection. patient states he felt better after vital signs assessed, will follow up with his dotor
shot given at 3:00 pm- at 7:00 started with raspy cough- then rapid heart beat- nearly fainted- diarrhea-chills-2x vomited- severe chills-then night sweats.  weakness the next day.
facility reported event as a seizure - transported by ambulance to ER and released after diagnosis of syncopal event.
Pt. assistant rash all over his body, especially the face since vx admin. in Dec. 2012. Also itching.
Initially palpitations/tachycardia noted shortly after vaccination, followed by nausea/vomiting and weight loss.  Now patient reports 3 weeks of neurologic symptoms of confusion/memory loss, disjointed thinking at times, intermittent blurry vision, muscle twitching, tingling in extremities and continued weight loss.  Patient recently "read online that CJD is commonly happening due to the vaccine" and fears that she has this herself.
Migraine, sore arm and tired. After about 4 hours, whole body aches and terrible nerve pain (not just muscular or skeletal). The nerve pain was quite unbearable. Severe pain lasted about 25 hours. For the following days exhaustion. After 10 days, full body rash, nerve pain (again), neuropathy-like symptoms, headache, beyond exhaustion, very off, whole body aches, pain in bottom of feet and hands and full body pain.